Medicare Enrolled
Dr. Juan Garza, M.D.
Medical Oncology · Tampa, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Garza from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Garza?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Garza
Dr. Juan Garza is a medical oncology specialist in Tampa, FL, with 12 years of NPI registration. Based on federal Medicare data, Dr. Garza performed 49,077 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Garza received a total of $20,090 from 73 pharmaceutical and/or device companies across 584 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Garza is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years of NPI registration
▲ Top 35% volume in FL
$20,090 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 167154 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗49,077
Medicare services
Top 35% in FL for medical oncology
Not available
Unique patients (not deduplicated)
$2
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
47,940 | $0 | $2 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
394 | $8 | $24 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
196 | $133 | $550 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
95 | $50 | $202 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
84 | $11 | $53 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
76 | $63 | $279 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
66 | $8 | $9 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
65 | $23 | $92 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
60 | $87 | $393 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
35 | $120 | $513 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
25 | $70 | $291 |
| New patient office visit, complex (60-74 min) | 21 | $168 | $671 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
20 | $139 | $556 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
98.0% high complexity
0.2% medium
1.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$20,090
Total received (2018-2024)
Avg $2,870/year across 7 years
Top 26% in FL for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
73
Companies
584
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,057
2023
$6,161
2022
$4,145
2021
$5,919
2020
$799
2019
$1,298
2018
$712
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$171
SpringWorks Therapeutics, Inc.
$152
BeiGene USA, Inc.
$106
PFIZER INC.
$80
AstraZeneca Pharmaceuticals LP
$78
Rigel Pharmaceuticals, Inc.
$56
SOBI, INC
$50
Lilly USA, LLC
$49
Genentech USA, Inc.
$38
ARRAY BIOPHARMA INC
$34
Janssen Biotech, Inc.
$30
Daiichi Sankyo Inc.
$29
Tempus AI, Inc
$28
Mirati Therapeutics, Inc.
$27
EMD Serono, Inc.
$25
Merck Sharp & Dohme LLC
$24
SERVIER PHARMACEUTICALS LLC
$23
Aveo Pharmaceuticals, Inc.
$21
Legend Biotech USA Inc.
$20
E.R. Squibb & Sons, L.L.C.
$17
Top 3 companies account for 40.6% of 2024 payments
All-time payments by company (2018-2024) ›
Eisai Inc.
$5,333
E.R. Squibb & Sons, L.L.C.
$1,378
Novartis Pharmaceuticals Corporation
$992
AstraZeneca Pharmaceuticals LP
$862
PFIZER INC.
$848
GENZYME CORPORATION
$675
Genentech USA, Inc.
$627
Merck Sharp & Dohme LLC
$561
Celgene Corporation
$496
Incyte Corporation
$480
Amgen Inc.
$479
Rigel Pharmaceuticals, Inc.
$465
Janssen Biotech, Inc.
$457
Lilly USA, LLC
$404
Seagen Inc.
$377
Merck Sharp & Dohme Corporation
$342
GlaxoSmithKline, LLC.
$316
Takeda Pharmaceuticals U.S.A., Inc.
$290
Pharmacyclics LLC, An AbbVie Company
$274
BeiGene USA, Inc.
$274
Astellas Pharma US Inc
$273
Kite Pharma, Inc.
$253
Gilead Sciences, Inc.
$238
Myovant Sciences Inc.
$189
Exelixis Inc.
$182
Daiichi Sankyo Inc.
$154
SpringWorks Therapeutics, Inc.
$152
Alexion Pharmaceuticals, Inc.
$142
Deciphera Pharmaceuticals Inc.
$132
Regeneron Healthcare Solutions, Inc.
$128
Lexicon Pharmaceuticals, Inc.
$125
Shire North American Group Inc
$124
Novo Nordisk Inc
$122
ABBVIE INC.
$110
SOBI, INC
$107
Pharmacosmos Therapeutics Inc.
$100
JAZZ PHARMACEUTICALS INC.
$98
Seattle Genetics, Inc.
$95
EMD Serono, Inc.
$94
Dova Pharmaceuticals
$91
AbbVie Inc.
$84
EISAI INC.
$79
TerSera Therapeutics LLC
$72
Sobi, Inc
$71
Puma Biotechnology, Inc.
$66
SERVIER PHARMACEUTICALS LLC
$62
ARRAY BIOPHARMA INC
$61
Immunomedics, Inc.
$59
Aveo Pharmaceuticals, Inc.
$55
PUMA BIOTECHNOLOGY, INC.
$52
Adaptive Biotechnologies Corporation
$49
Boston Scientific Corporation
$47
Mirati Therapeutics, Inc.
$46
Myriad Genetic Laboratories, Inc.
$41
Genmab U.S., Inc.
$37
Servier Pharmaceuticals LLC
$35
Clovis Oncology, Inc.
$32
Tempus AI, Inc
$28
Pharming Healthcare, Inc.
$23
Stemline Therapeutics Inc.
$23
Sirtex Medical Inc
$22
Apellis Pharmaceuticals, Inc.
$21
Janssen Pharmaceuticals, Inc
$21
Legend Biotech USA Inc.
$20
AVEO Pharmaceuticals, Inc.
$19
MorphoSys, US Inc.
$19
Emmaus Medical, Inc.
$18
Bayer HealthCare Pharmaceuticals Inc.
$18
Acceleron Pharma, Inc.
$17
Sumitomo Pharma America, Inc.
$16
Allergan, Inc.
$14
Secura Bio, Inc.
$12
Ipsen Biopharmaceuticals, Inc
$12
Top 3 companies account for 38.3% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ALIMTA · ALUNBRIG · Alecensa · Avastin · BAVENCIO · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELIQUIS · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Empaveli · Endari · Enhertu · FARYDAK · FOTIVDA · FRUZAQLA · Fabhalta · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · Itovebi · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · Nplate · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · Padcev · Phesgo · Polivy · Pomalyst · QINLOCK · REBLOZYL · RUCONEST · RYBREVANT · Reblozyl · Rezlidhia · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · TABRECTA · TAGRISSO · TALZENNA · TASIGNA · TECENTRIQ · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · TheraSphere Y90 Glass Microspheres 10 GBq · Tibsovo · Trodelvy · UBRELVY · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VONVENDI · VYXEOS · Venclexta · Wegovy · XALKORI · XARELTO · XGEVA · XOSPATA · XT CDX · XTANDI · XYNTHA · Xermelo · Xofigo · Xtandi · Yescarta · ZEJULA · ZOLADEX · clonoSEQ · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
65
County median income
$75,011
Nearest hospital to ZIP centroid (approximate)
ST JOSEPHS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Garza is a mixed practice specialist, with moderate Medicare volume.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Garza experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Garza performed 47,940 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Garza receive payments from pharmaceutical companies?
Yes. Dr. Garza received a total of $20,090 from 73 companies across 584 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Garza's costs compare to other medical oncologists in Tampa?
Dr. Garza's average Medicare payment per service is $2. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Garza) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Tampa
Browse medical oncologists in Tampa ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in FL
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in FL
Which FL medical oncologists receive the most from drug and device companies.
By company
Eisai Inc. Payments to Doctors
See all physicians who received payments from Eisai Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology